Skip to content

CareDx CDNA Free cash flow margin

Free cash flow margin at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
15.7%-2.1pp
Natera, Inc. logo
Natera, Inc.NTRA
4.2%-0.5pp
NeoGenomics logo
NeoGenomicsNEO
-4.9%
Personalis, Inc. logo
Personalis, Inc.PSNL
-131.2%-453pp
GeneDx Holdings logo
GeneDx HoldingsWGS
3.8%+2.1pp
TransMedics Group, Inc. logo
TransMedics Group, Inc.TMDX
23.8%

Other financials

Income statement

See full
Revenue$117.7M+39.0%
Operating income$1.2M+109%
Net income$2.8M+127%
EPS (diluted)$0.05+126%

Balance sheet

See full
Cash & equivalents$78.5M-12.1%
Total debt$24.5M-19.1%
Total equity$313.5M-17.3%
Total assets$411.1M-16.0%

Cash flow

See full
Operating cash flow$4.3M+116%
CapEx$3.8M+134%
Free cash flow$514.0K+102%

Valuation

See full
Market cap$1.4B-9.6%
Enterprise value$1.35B-9.7%
P/S3.4×-1.1×

Profitability

See full
Gross margin65.5%
Operating margin-3.9%-18.3pp
Net margin-2%-19.9pp

Returns & leverage

See full
Return on equity-2.4%-21.9pp
Debt / equity0.1×0.0×
Current ratio3.4×-0.7×

Where this comes from

Calculated from CareDx’s reported figures.

Based on trailing twelve months.

The official record: CareDx’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about CareDx's free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CareDx's free cash flow margin?
CareDx (CDNA) reported free cash flow margin of -0% in Q1 2025.
How has CareDx's free cash flow margin changed year-over-year?
CareDx's free cash flow margin increased by 97.5% year-over-year, from -1.8% to -0%.
What is the long-term trend for CareDx's free cash flow margin?
Over 3 years (2020 to 2024), CareDx's free cash flow margin has grown at a -13.4% compound annual growth rate (CAGR), from 17.3% to 11.2%.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.